The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| XLY | +244.44% | -36.73% | -8.75% | -89% |
| S&P | +18.33% | +108.18% | +15.79% | +1,888% |
Auxly Cannabis Group, Inc. engages in developing, manufacturing, and distributing branded cannabis products for wellness and recreational consumers. It operates through the following segments: Canadian Cannabis Operations, Research Operations, and South American Cannabis Operations. The Canadian Cannabis Operations segment includes cultivation and sale of cannabis and cannabis 2.0 products within Canada. The Research Operations segment offers research services for customers who are conducting human clinical trials. The South American Cannabis Operations segment refers to cultivation of cannabis products through Inverell SA. The company was founded by Hugo M. Alves on August 24, 1987 and is headquartered in Toronto, Canada.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $38.80M | 33.0% |
| Gross Profit | $5.57M | -7.8% |
| Gross Margin | 14.36% | -6.4% |
| Market Cap | $131.82M | 254.7% |
| Market Cap / Employee | $0.34M | 0.0% |
| Employees | 388 | 5.1% |
| Net Income | $8.31M | 315.1% |
| EBITDA | -$2.78M | -147.8% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $17.28M | 14.3% |
| Accounts Receivable | $21.25M | 13.7% |
| Inventory | 40.4 | 20.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $12.99M | -77.1% |
| Short Term Debt | $48.61M | 112.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 10.82% | 26.5% |
| Return On Invested Capital | -27.95% | 3.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $3.10M | 64.3% |
| Operating Free Cash Flow | $3.33M | 13.6% |
| Metric | Q1 2025 | Q2 2025 | YoY Change | ||
|---|---|---|---|---|---|
| Price to Earnings | 4.76 | 4.63 | - | ||
| Price to Book | 0.41 | 0.46 | 0.90 | 1.02 | 184.25% |
| Price to Sales | 0.41 | 0.45 | 0.84 | 1.06 | 196.03% |
| Price to Tangible Book Value | 0.57 | 0.63 | 1.22 | 1.33 | 162.91% |
| Price to Free Cash Flow TTM | 2.51 | 3.95 | 5.92 | 7.49 | 74.25% |
| Enterprise Value to EBITDA | -80.87 | -38.49 | -44.38 | -69.02 | -25.21% |
| Free Cash Flow Yield | 39.8% | 25.3% | 16.9% | 13.3% | -42.61% |
| Return on Equity | -69.4% | -19.6% | 18.7% | 23.0% | -145.17% |
| Total Debt | $71.64M | $68.48M | $65.30M | $61.59M | -22.53% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
